NRC Health Operating Expenses
NRC Health (NRC) reported Operating Expenses of $21.27 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-08-08
- NRC Health operating expenses for the quarter ending 2019-06-30 was $21.27M, a 4.96% increase year-over-year.
- NRC Health operating expenses for the quarter ending 2019-03-31 was $20.78M, a 5.82% decline year-over-year.
- NRC Health operating expenses for the quarter ending 2018-12-31 was $21.24M, a 0.03% increase year-over-year.
- NRC Health operating expenses for the quarter ending 2018-09-30 was $20.85M, a 4.50% decline year-over-year.
- NRC Health operating expenses for fiscal 2018 was $84.41M, a 1.29% increase from fiscal 2017.
- NRC Health operating expenses for fiscal 2017 was $83.34M, a 6.59% increase from fiscal 2016.
- NRC Health operating expenses for fiscal 2016 was $78.19M, a 3.02% increase from fiscal 2015.
- NRC Health operating expenses for fiscal 2015 was $75.90M, a 7.59% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-06-30 | $21.27M 10-Q · filed 2019-08-08 | $42.04M 10-Q · filed 2019-08-08 | $63.28M derived: sum of 3 quarters · filed 2019-08-08 | $84.13M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $20.78M 10-Q · filed 2019-05-08 | $42.02M derived: sum of 2 quarters · filed 2019-05-08 | $62.87M derived: sum of 3 quarters · filed 2019-05-08 | $83.13M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-12-31 | $21.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $42.09M derived: sum of 2 quarters · filed 2019-03-08 | $62.35M derived: sum of 3 quarters · filed 2019-08-08 | $84.41M 10-K · filed 2019-03-08 |
| 2018-09-30 | $20.85M 10-Q · filed 2018-11-08 | $41.11M derived: sum of 2 quarters · filed 2019-08-08 | $63.17M 10-Q · filed 2018-11-08 | $84.40M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $20.26M 10-Q · filed 2019-08-08 | $42.32M 10-Q · filed 2019-08-08 | $63.56M derived: sum of 3 quarters · filed 2019-08-08 | $85.39M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $22.06M 10-Q · filed 2019-05-08 | $43.30M derived: sum of 2 quarters · filed 2019-05-08 | $65.13M derived: sum of 3 quarters · filed 2019-05-08 | $85.11M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $21.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $43.07M derived: sum of 2 quarters · filed 2019-03-08 | $63.05M derived: sum of 3 quarters · filed 2019-03-08 | $83.34M 10-K · filed 2019-03-08 |
| 2017-09-30 | $21.83M 10-Q · filed 2018-11-08 | $41.81M derived: sum of 2 quarters · filed 2018-11-08 | $62.10M 10-Q · filed 2018-11-08 | $81.64M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $19.98M 10-Q · filed 2018-08-09 | $40.27M 10-Q · filed 2018-08-09 | $59.81M derived: sum of 3 quarters · filed 2019-03-08 | $79.50M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $20.29M 10-Q · filed 2018-05-04 | $39.83M derived: sum of 2 quarters · filed 2019-03-08 | $59.52M derived: sum of 3 quarters · filed 2019-03-08 | $78.61M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $39.23M derived: sum of 2 quarters · filed 2019-03-08 | $58.32M derived: sum of 3 quarters · filed 2019-03-08 | $78.19M 10-K · filed 2019-03-08 |
| 2016-09-30 | $19.69M 10-Q · filed 2017-11-09 | $38.79M derived: sum of 2 quarters · filed 2017-11-09 | $58.65M 10-Q · filed 2017-11-09 | $77.31M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $19.10M 10-Q · filed 2017-08-04 | $38.96M 10-Q · filed 2017-08-04 | $57.62M derived: sum of 3 quarters · filed 2018-03-14 | $76.31M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $19.86M 10-Q · filed 2017-05-05 | $38.52M derived: sum of 2 quarters · filed 2018-03-14 | $57.22M derived: sum of 3 quarters · filed 2018-03-14 | $75.32M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $18.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $37.35M derived: sum of 2 quarters · filed 2018-03-14 | $55.45M derived: sum of 3 quarters · filed 2018-03-14 | $75.90M 10-K · filed 2018-03-14 |
| 2015-09-30 | $18.70M 10-Q · filed 2016-11-04 | $36.80M derived: sum of 2 quarters · filed 2016-11-04 | $57.24M 10-Q · filed 2016-11-04 | $75.94M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $18.10M 10-Q · filed 2016-08-05 | $38.54M 10-Q · filed 2016-08-05 | $57.25M derived: sum of 3 quarters · filed 2017-03-03 | $73.77M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $20.44M 10-Q · filed 2016-05-06 | $39.15M derived: sum of 2 quarters · filed 2017-03-03 | $55.67M derived: sum of 3 quarters · filed 2017-03-03 | $73.35M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $18.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $35.23M derived: sum of 2 quarters · filed 2017-03-03 | $52.91M derived: sum of 3 quarters · filed 2017-03-03 | $70.54M 10-K · filed 2017-03-03 |
| 2014-09-30 | $16.52M 10-Q · filed 2015-11-05 | $34.21M derived: sum of 2 quarters · filed 2015-11-05 | $51.84M 10-Q · filed 2015-11-05 | $68.73M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $17.68M 10-Q · filed 2015-08-06 | $35.31M 10-Q · filed 2015-08-06 | $52.21M derived: sum of 3 quarters · filed 2016-03-04 | $68.59M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $17.63M 10-Q · filed 2015-05-08 | $34.53M derived: sum of 2 quarters · filed 2016-03-04 | $50.91M derived: sum of 3 quarters · filed 2016-03-04 | $67.72M derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $16.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $33.27M derived: sum of 2 quarters · filed 2016-03-04 | $50.09M derived: sum of 3 quarters · filed 2016-03-04 | $67.78M 10-K · filed 2016-03-04 |
| 2013-09-30 | $16.38M 10-Q · filed 2014-11-07 | $33.20M derived: sum of 2 quarters · filed 2014-11-07 | $50.89M 10-Q · filed 2014-11-07 | $67.11M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-06-30 | $16.82M 10-Q · filed 2014-08-06 | $34.51M 10-Q · filed 2014-08-06 | $50.73M derived: sum of 3 quarters · filed 2015-03-04 | $66.47M derived: sum of 4 quarters · filed 2015-03-04 |
| 2013-03-31 | $17.69M 10-Q · filed 2014-05-08 | $33.91M derived: sum of 2 quarters · filed 2015-03-04 | $49.65M derived: sum of 3 quarters · filed 2015-03-04 | $65.07M derived: sum of 4 quarters · filed 2015-03-04 |
| 2012-12-31 | $16.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $31.96M derived: sum of 2 quarters · filed 2015-03-04 | $47.38M derived: sum of 3 quarters · filed 2015-03-04 | $63.70M 10-K · filed 2015-03-04 |
| 2012-09-30 | $15.74M 10-Q · filed 2013-11-07 | $31.16M derived: sum of 2 quarters · filed 2013-11-07 | $47.48M 10-Q · filed 2013-11-07 | $61.58M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | $15.42M 10-Q · filed 2013-08-08 | $31.74M 10-Q · filed 2013-08-08 | $45.84M derived: sum of 3 quarters · filed 2014-03-04 | $60.20M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | $16.32M 10-Q · filed 2013-05-08 | $30.43M derived: sum of 2 quarters · filed 2014-03-04 | $44.78M derived: sum of 3 quarters · filed 2014-03-04 | $59.27M derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $28.46M derived: sum of 2 quarters · filed 2014-03-04 | $42.94M derived: sum of 3 quarters · filed 2014-03-04 | $57.03M 10-K · filed 2014-03-04 |
| 2011-09-30 | $14.36M 10-Q · filed 2012-11-07 | $28.84M derived: sum of 2 quarters · filed 2012-11-07 | $42.93M 10-Q · filed 2012-11-07 | $56.45M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $14.48M 10-Q · filed 2012-08-10 | $28.58M 10-Q · filed 2012-08-10 | $42.10M derived: sum of 3 quarters · filed 2013-03-01 | $54.61M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $14.09M 10-Q · filed 2012-05-11 | $27.61M derived: sum of 2 quarters · filed 2013-03-01 | $40.13M derived: sum of 3 quarters · filed 2013-03-01 | $51.61M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $13.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $26.04M derived: sum of 2 quarters · filed 2013-03-01 | $37.52M derived: sum of 3 quarters · filed 2013-03-01 | $49.54M 10-K · filed 2013-03-01 |
| 2010-09-30 | $12.51M 10-Q · filed 2011-11-08 | $23.99M derived: sum of 2 quarters · filed 2011-11-08 | $36.02M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $11.48M 10-Q · filed 2011-08-12 | $23.50M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $43.99M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |